Transchem Ltd
Incorporated in 1976, Transchem Ltd is engaged in the business of Mushroom production and processing.
- Market Cap ₹ 217 Cr.
- Current Price ₹ 177
- High / Low ₹ 194 / 35.2
- Stock P/E 50.4
- Book Value ₹ 68.3
- Dividend Yield 0.00 %
- ROCE 6.89 %
- ROE 5.28 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
Cons
- Stock is trading at 2.59 times its book value
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has a low return on equity of 5.98% over last 3 years.
- Earnings include an other income of Rs.9.26 Cr.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.05 | -0.20 | 0.00 | 0.34 | 2.57 | 0.00 | |
| 0.78 | 0.93 | 0.98 | 1.69 | 1.18 | 1.39 | 1.88 | 2.54 | 1.73 | 2.08 | 4.03 | 3.64 | |
| Operating Profit | -0.78 | -0.93 | -0.98 | -1.69 | -1.18 | -1.39 | -1.93 | -2.74 | -1.73 | -1.74 | -1.46 | -3.64 |
| OPM % | -511.76% | -56.81% | ||||||||||
| 2.09 | 1.97 | 1.78 | 2.11 | 2.75 | 2.76 | 26.82 | 6.66 | 4.24 | 7.40 | 8.53 | 9.26 | |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 1.07 | 1.02 | 1.02 | 0.97 | 0.80 | 0.57 | 0.12 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Profit before tax | 0.24 | 0.02 | -0.22 | -0.55 | 0.77 | 0.80 | 24.77 | 3.91 | 2.50 | 5.65 | 7.06 | 5.61 |
| Tax % | 45.83% | -150.00% | 0.00% | 116.36% | 61.04% | 47.50% | 2.50% | 26.60% | 50.80% | 25.66% | 26.06% | 23.53% |
| 0.12 | 0.05 | -0.22 | -1.19 | 0.31 | 0.41 | 24.15 | 2.87 | 1.24 | 4.20 | 5.23 | 4.30 | |
| EPS in Rs | 0.10 | 0.04 | -0.18 | -0.97 | 0.25 | 0.33 | 19.73 | 2.34 | 1.01 | 3.43 | 4.27 | 3.51 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | -100% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 56% |
| 5 Years: | 14% |
| 3 Years: | 58% |
| TTM: | -18% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 26% |
| 5 Years: | 48% |
| 3 Years: | 102% |
| 1 Year: | 334% |
| Return on Equity | |
|---|---|
| 10 Years: | 3% |
| 5 Years: | 5% |
| 3 Years: | 6% |
| Last Year: | 5% |
Balance Sheet
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 12.24 | 12.24 | 12.24 | 12.24 | 12.24 | 12.24 | 12.24 | 12.24 | 12.24 | 12.24 | 12.24 | 12.24 |
| Reserves | 26.11 | 26.15 | 25.75 | 24.57 | 25.74 | 24.53 | 50.70 | 54.06 | 53.60 | 63.41 | 67.08 | 71.34 |
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| 0.22 | 0.23 | 0.17 | 0.17 | 0.39 | 0.30 | 0.48 | 0.51 | 0.39 | 0.66 | 0.40 | 4.15 | |
| Total Liabilities | 38.57 | 38.62 | 38.16 | 36.98 | 38.37 | 37.07 | 63.42 | 66.81 | 66.23 | 76.31 | 79.72 | 87.73 |
| 8.40 | 7.42 | 6.40 | 5.43 | 4.27 | 3.70 | 0.11 | 0.10 | 0.09 | 0.09 | 0.05 | 0.02 | |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 27.50 | 28.01 | 29.79 | 10.21 | 5.93 | 3.69 | 8.69 | 8.82 | 8.23 | 8.91 | 2.04 | 1.97 |
| 2.67 | 3.19 | 1.97 | 21.34 | 28.17 | 29.68 | 54.62 | 57.89 | 57.91 | 67.31 | 77.63 | 85.74 | |
| Total Assets | 38.57 | 38.62 | 38.16 | 36.98 | 38.37 | 37.07 | 63.42 | 66.81 | 66.23 | 76.31 | 79.72 | 87.73 |
Cash Flows
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.94 | 1.08 | 0.55 | -19.79 | 10.34 | -0.63 | -27.72 | 21.91 | 1.22 | -39.31 | 36.00 | -1.57 | |
| -1.21 | -0.26 | -1.51 | 19.78 | 5.73 | 0.67 | 23.06 | 0.60 | -0.94 | 5.12 | 6.02 | 1.65 | |
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Cash Flow | -0.27 | 0.83 | -0.95 | -0.01 | 16.07 | 0.04 | -4.66 | 22.51 | 0.28 | -34.18 | 42.02 | 0.09 |
| Free Cash Flow | 0.94 | 1.04 | 0.55 | -19.79 | 10.53 | -0.63 | -1.79 | 21.91 | 1.22 | -39.31 | 36.53 | 0.01 |
| CFO/OP | -121% | -116% | -56% | 1,165% | -897% | 0% | 1,401% | -853% | -132% | 2,182% | -2,618% | 10% |
Ratios
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 0.00 | 0.00 | 440.15 | 384.88 | ||||||||
| Inventory Days | 35,770.00 | 32,485.00 | -511.00 | -273.75 | 0.00 | 0.00 | ||||||
| Days Payable | 0.00 | 0.00 | ||||||||||
| Cash Conversion Cycle | -511.00 | -273.75 | 440.15 | 384.88 | ||||||||
| Working Capital Days | 311,418.00 | 42,705.00 | 71,421.91 | 4,970.82 | ||||||||
| ROCE % | 0.63% | 0.05% | -0.58% | -1.47% | 1.63% | 2.03% | 4.61% | 4.22% | 3.50% | 7.99% | 9.11% | 6.89% |
Insights
In beta| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Number of Active Manufacturing Plants Count |
|
||||||||||
| Revenue from Operations (Trading Performance) INR Lakhs |
|||||||||||
| Revenue per Employee INR Lakhs/Employee |
|||||||||||
| Number of Permanent Employees Count |
|||||||||||
| Purchase of Stock-In-Trade (Agricultural Goods) INR Lakhs |
|||||||||||
Extracted by Screener AI
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Change in Management
1d - Transchem reappointed M/s. L. T. Jadav & Co. as internal auditors for FY 2026-2027 on May 05, 2026.
- Audited Financial Results For The Quarter And Year Ended March 31, 2026 1d
-
Board Meeting Outcome for The Meeting Held On May 05, 2026, Under Regulation 30 Of The SEBI (LODR) Regulations, 2015
1d - Board approved FY26 audited results; net profit ₹429.51 lakh, and reappointed internal auditors for FY27.
-
Board Meeting Intimation for Approval Of Audited Financial Results For The Quarter And Year Ended March 31, 2026.
28 Apr - Board meets May 5, 2026 to approve audited FY26 results; trading window closed from April 1, 2026.
-
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
15 Apr - Transchem confirms non-applicability of Large Corporate framework for FY2026; outstanding borrowings were nil.
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
Operational Status:[1][2]
Company was in the business of Mushroom production and operated a 100% Export Oriented Unit from its manufacturing plant in Pune. But due to change in international horticulture scenario, the mushroom plant of company is non-operational since several years. In FY20, the manufacturing plant has been monetized by company after getting applicable legal consents and approvals. At present, management of company is looking forward for new opportunities to utilize the funds of company. Company has temporarily invested its funds in short term treasury operations.